Posterior capsule opacification after cataract surgery in patients with diabetes mellitus

Ebihara, Yoshinori; Kato, Satoshi; Oshika, Tetsuro; Yoshizaki, Mayumi; Sugita, Gentaro

doi:10.1016/j.jcrs.2006.01.100

Cited by 66 publications

(43 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[16][17][18] But the higher incidence of PCO and surface changes could not be explained in hypertensive patients. 19 Several studies showed that IOLs have an important role in capsular opacification and capsular fibrosis, after extracapsular cataract extraction and PCIOL implantation. Anterior capsular opacification (ACO) usually occurs where capsule comes in contact with the IOL after in-the-bag implantation.…”

Section: Discussionmentioning

confidence: 99%

Posterior Capsular Changes and Its Association With Posterior Chamber Intraocular Lens Surface Changes After Extracapsular Cataract Extraction

A¹,

Achar²

2017

jemds

View full text Add to dashboard Cite

BACKGROUNDPosterior Capsular Opacification is the most frequent complication of cataract surgery. There are few studies that determine the changes in the lens surfaces with the posterior capsular changes. The objectives of the present study were to report intraocular lens surface changes and posterior capsular changes after extracapsular cataract extraction with posterior chamber intra-ocular lens (ECCE-PCIOL) implantation surgeries, and to determine the factors influencing the anterior surface changes.

show abstract

Section: Discussionmentioning

confidence: 99%

Posterior Capsular Changes and Its Association With Posterior Chamber Intraocular Lens Surface Changes After Extracapsular Cataract Extraction

A¹,

Achar²

2017

jemds

View full text Add to dashboard Cite

show abstract

“…To properly judge the potential of a new IOLs or a surgical method to prevent PCO, a long-term followup (usually 3 years or longer) of the included eyes is necessary 27 . We observed the PCO at 1-year intervals up to 8 years after cataract surgery; therefore the PCO change over longer period of time was assessed.…”

Section: Discussionmentioning

confidence: 99%

Long-term follow-up of posterior capsule opacification after AquaLase and NeoSoniX phacoemulsification

Stepanov¹,

Nekolová²,

Jirásková³

et al. 2016

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub

View full text Add to dashboard Cite

Aim.To compare the degree of posterior capsule opacification (PCO) after AquaLase and NeoSoniX phacoemulsification methods during an 8-year follow-up period using two types of software. Design. Prospective, randomized clinical trial. Methods. AquaLase was used in the right eye and NeoSoniX in the left eye of each patient with bilateral cataract. Results. Fifty patients were analyzed 1 year, 46 patients 3 years, and 37 patients 8 years after cataract surgery. Mean EPCO 2000 values were for the AquaLase group 0.324 ± 0.305 and for the NeoSoniX group 0.298 ± 0.341 (P = 0.53) 1 year after surgery, for the AquaLase group 0.582 ± 0.506 and for the NeoSoniX group 0.594 ± 0.515 (P = 0.87) 3 years after surgery, and for the AquaLase group 0.648 ± 0.567 and for the NeoSoniX group 0.673 ± 0.542 (P = 0.30) 8 years after surgery. The OSCA results were for the AquaLase group 0.7097 ± 0.3778 and for the NeoSoniX group 0.8584 ± 0.4323 (P = 0.046) 1 year after surgery, for the AquaLase group 0.9667 ± 0.736 and for the NeoSoniX group 0.9540 ± 0.5250 (P = 0.91) 3 years after surgery, and for the AquaLase group 1,035 ± 0,952 and for the NeoSoniX group 1,103 ± 0,741 (P = 0.44) 8 years after surgery. Conclusion. There was minimal PCO difference between these 2 approaches, AquaLase and NeoSoniX. Neither AquaLase nor NeoSoniX technique was able to prevent a natural progression of PCO.

show abstract

“…1,2 PCO is also a frequent and important complication noticed in diabetics undergoing cataract surgery. [3][4][5][6][7][8][9] It has the potential to obscure fundus view, thereby compromising the observation and timely treatment of posterior segment pathologies such as diabetic retinopathy (DR) and macular edema.…”

Section: Introductionmentioning

confidence: 99%

“…[7][8][9] However, some studies have reported contradictory results regarding the prevalence of PCO in diabetic vs non-diabetic patients. [3][4][5][6] A few studies have quantitatively evaluated PCO; the results, however, are still controversial.…”

Section: Introductionmentioning

confidence: 99%

“…[3][4][5][6] A few studies have quantitatively evaluated PCO; the results, however, are still controversial. 4,8,9 There is paucity of available literature that prospectively evaluates the development of PCO with the implantation of a single-piece hydrophobic acrylic intraocular lens (IOL) in diabetic vs non-diabetic eyes on a long-term basis. Therefore, this study was designed to compare the degree of PCO after cataract surgery between age-matched diabetic and nondiabetic patients.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

A prospective evaluation of posterior capsule opacification in eyes with diabetes mellitus: a case–control study

Praveen

Vasavada

Shah

et al. 2014

Eye

View full text Add to dashboard Cite

Aim To compare the development of posterior capsule opacification (PCO) between eyes with and without diabetes mellitus after single-piece hydrophobic acrylic intraocular lens implantation 4 years postoperatively. Methods In this prospective, observational case-control study carried out at Iladevi Cataract and IOL Research Centre, Ahmedabad, India, 75 consecutive eyes with diabetes mellitus (cases) were compared with 75 age-matched eyes with age-related cataract (controls). A detailed, preoperative and posterior segment evaluation was carried out in eyes with diabetes mellitus to detect the presence or absence of diabetic retinopathy (DR). The Mann-Whitney U-test was applied to compare the differences in the development of PCO between the two groups. Results There was no difference in median PCO between cases and controls at 1 month (2.0 vs 1.50, Po0.068), but cases had a higher median PCO at 12 months (2.95 vs 1.30, Po0.001). At 4 years, there was no significant difference in median PCO between cases and controls (3.75 vs 2.25, P ¼ 0.273). The duration of diabetes increased the incidence of PCO at 4 years (P ¼ 0.02). Severity of DR had no influence on the progress of PCO at 4 years (P ¼ 0.69). Conclusion Diabetes mellitus did not increase the incidence of PCO at 4 years. The duration of diabetes increased the risk of PCO. The severity of retinopathy did not influence the development of PCO.

show abstract

Posterior capsule opacification after cataract surgery in patients with diabetes mellitus

Abstract: Diabetic patients had significantly more severe PCO after cataract surgery than nondiabetic patients.

Cited by 66 publications

References 13 publications

Posterior Capsular Changes and Its Association With Posterior Chamber Intraocular Lens Surface Changes After Extracapsular Cataract Extraction

Posterior Capsular Changes and Its Association With Posterior Chamber Intraocular Lens Surface Changes After Extracapsular Cataract Extraction

Long-term follow-up of posterior capsule opacification after AquaLase and NeoSoniX phacoemulsification

A prospective evaluation of posterior capsule opacification in eyes with diabetes mellitus: a case–control study

Contact Info

Product

Resources

About